Enhanced oxidative stress with a gradient between plasma and muscle interstitial fluid in patients with end stage renal failure on hemodialysis

Hormones

Volumn 7, Issue 1, 2008, Pages 62-69

  Karamouzis, Ioannis ^a   Grekas, Dimitrios ^b   Karamouzis, Michael ^a   Triantos, Athanasios ^a   Vasileva Staikova, Svetla ^c   Kovachev, Dimitrios ^d   Dimitriadou, Afroditi ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^d UNIVERSITY OF ECONOMICS VARNA   (Bulgaria)

Author keywords

15 F2t isoprostane; Hemodialysis; Lipid peroxidation; Microdialysis; Renal failure

Indexed keywords

8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DRUG EFFECT; ENZYME IMMUNOASSAY; EXTRACELLULAR FLUID; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MICRODIALYSIS; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY;

DINOPROST; EXTRACELLULAR FLUID; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; MALE; MICRODIALYSIS; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 42449116995     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1111038     Document Type: Article

References (38)

1. Chiabrando C, Rivalta C, Bagnati R, et al, 2002 Identification of metabolites from type III F2-isoprostane diastereoisomers by masspectrometry. J Lipid Research 43: 495-509.
2. Roberts LJ, Morrow JD, 2000 Measurement of F2-isoprostanes as index of oxidative stress in vivo. Free Radical Biol Med 28: 505-513.
3. Lawson JA, Rokain J, Fitzgerald GA, 1999 Isoprostane: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem 274: 24441-24444.
4. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ 2nd, 1990 A series of prostaglandin F2-like compounds are produced in vivo in human by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383-9387.
5. Morrow JD, Minton TA, Roberts LJ 2nd, 1992 The F2-isoprostane, 8-epi-prostaglandin F2a, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 44: 155-163.
6. Malla Z, Philip I, Lebret M, Chatel D, Maclouf J, Tadgui A, 1998 Elevated levels of 8-iso-prostaglandin F2· in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97: 1536-1539.
7. Murai Y, Hishinuma, T, Suzuki N, Satoh J, Toyota T, Mizugaki M, 2000 Determination of 8-epi-prostaglandin F (2alpha) using liquid chromatography-tandem mass spectrometry: increased excretion in diabeticsî. Prostaglandins Other Lipid Mediat 62: 173-181.
8. Cracowski JL, Cracowski C, Bessard G, et al, 2001 Increased lipid peroxidation in patients with pulmonary hypertension. Am J Crit Care Med 164: 1038-1042.
9. Basu S, Whiteman M, Mattey DL, Halliwell B, 2001 Raised levels of F2-isoprostanes and prostaglandin F2· in different rheumatic diseases. Ann Rheum Dis 60: 627-631.
10. Handelman GJ, Walter MF, Adhikarla R, et al, 2001 Elevated plasma F2-isoprostanes in patients on long term hemodialysis. Kidney Int 59: 1960-1966.
11. ZouRooz-Zadeh J, 1999 Effect of dialysis on oxidative stress in uremia. Redox Rec 4: 17-32.
12. Massy ZA, Nguyen-Khoa T, 2002 Oxidative stress and chronic renal failure: Markers and management. J Nephrol 15: 336-341.
13. Amberg G, Lindefors N, 1989 Intracerebral microdialysis: II. Mathematical studies of diffusion kinetics. J Pharm Methods 22: 157-183.
14. Simonsen L, Blow J, Madsen J, 1994 Adipose tissue metabolism in humans determined by vein catheterization and microdialysis techniques. Am J Physiol (Endocrine metab. 29) q 266(3Pt1): E 357-365.
15. Maggs DG, Jacob R, Rife F, et al, 1995 Interstitial fluid concentrations of glycerol, glucose and amino acids in human quadriceps and adipose tissue. J Clin Invest 96: 370-377.
16. Langberg H, Skovgaard D, Karamouzis M, Bllow J, Kjaer M, 1999 Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis. J Physiol 515: 919-927.
17. Karamouzis M, Lanberg H, Kjaer M, Blow J, Saltin B, 1999 A comparative study of the influence of dynamic and static isometric intermittent contractions on the intramuscular accumulation of prostaglandins and thromboxanes: A study with microdialysis. Medical Biochemistry 1: 233-245.
18. Karamouzis, Christoulas K, Grekas D, Giannoulis Kl, Vamvakoudis E, Mandroukas K, 2004 The response of muscle interstitial F2-isoprostane (8-iso-PGF2α) during dynamic contractions in humans. Prostaglandins Leukotrienes and Essential Fatty Acids 71: 87-90.
19. Walter M, Blumberg J, Dolnikowsi Gr, Handelman G, 2000 Streamlined F2-isoprostane analysis in plasma and urine with HPLC gas chromatography/mass spectroscopy. Analytical Biochemistry 280: 73-79.
20. Ikizler TA, Morrow JD, Roberts LJ, et al, 2002 Plasma F2-isoprostane levels are elevated in chronic hemodialysis patient. Clin Nephrol 58: 190-197.
21. Spittle MA, Holnich NA, Handelman GJ, Adhanarea R, Home P, 2002 Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis 38: 1408-14013.
22. Lim PS, Chang YM, Thien LM, et al, 2002 8-iso-prostaglandin F2· as a useful biomarker of oxidation stress in ESRD patients. Blood Purif 20: 537-542.
23. Ferraro B, Galli F, Frei B, et al, 2003 Peroxynitrite-Induced oxidation plasma lipid is enhanced in stable hemodialysis patients. Kidney Int 63: 2007-2213.
24. Kim K, Jung B, Paeng KJ, Kim SW, Chung BC, 2004 Alteration of plasma total F2-isoprostane before and after hemodialysis in end-stage renal disease patients. Prostaglandins Leukot Essent Fatty Acids 70: 475-478.
25. Hofman SW, Roof RL, Stein DG, 1996 A reliable and sensitive enzyme immunoassay method for measuring 8-iso-prostaglandin F2·. A marker for lipid peroxidation after experimental brain injury. J Neurosci Ãethods 68: 133-136.
26. Maxey KM, Maddipati KR, Birkeier J, 1992 Interference in enzyme immunoassay. J Clin Immunoassay 15: 116-120.
27. Grundmen JU, Wiswedele D, Hirsch D, Gollnick HP, 2004 Detection of monohydroxylicosa retranoic acid and F2-isoprostanel in microdialysis samples of human UV irradiation skin by gas chromatography mass spectrometry. Skin Pharmacol Physiol 17: 37-41.
28. Dietrich M, Block G, Benowitz NL, et al, 2003 Vitamin C supplementation decreases oxidative stress biomarkers F2-isoprostanes in plasma of nonsmokers exposed to environmental tobacco smoke. Nutr Cancer 45: 176-184.
29. Moreno JJ, Carbonell T, Sanchez T, Miret S, Mitjavila MT, 2001 Olive oil decrease both oxidative stress and production of arachidonic acid metabolites by the prostaglandin G/H synthase pathway in rat macrophages. J Nutr 131: 2145-2149.
30. Wolfam M, Oguogho A, Efthimiou Y, Budinsky G, Sinzinger H, 2002 Effect of black tea on iso-prostaglandins and platelet aggregation in healthy volunteers. Prostaglandis Leukot Essent Fatty Acids 65: 529-533.
31. Kegs A, 1999 Mediterranean diet and public health personal reflection. Am J Clin Nutr 61: 1321-1323.
32. Karamouzis I, Grekas D, Karamouzis M, et al, 2004 The changes of isoprostane 8-iso-PGF2α, in the intracellurar fluids of muscle, hemodialysed patients. Helliniki Iatriki 70: 279-285. (abstract in English)
33. Ward RA, McLeish KR, 1995 Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs 19: 801-807.
34. Canaud B, Cristol J, Morena M, Leray-Moragues H, Bosc J, Vaussenat F, 1999 Imbalance of oxidants and antioxidants in hemodialysis patients. Blood Purif 17: 99-106.
35. Ward RA, McLeish KR, 1995 Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 5: 1697-1702.
36. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER, 1994 Oxidative stress in hemodialysis. Quan J Med 87: 679-683.
37. Morena M, Cristol JP, Bosc JY, et al, 2002 Connective and diffusive losses of vitamin C during hemodiafiltration session: a contributive factor to oxidative stress in hemodialysis patients. Nephrol Dial Transplant 17: 422-427.
38. Koenig JS, Fischer M, Bulant E, Tiran B, Elmadfa I, Druml W, 1997. Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr 109: 13-19.